They give me very good support on my research and are together with me all the time. With the help from them, I made good progress with my research, which provides further understanding of B cell lymphomas.
I was awarded CRI fellowship to conduct my research at the University of Chicago. This helped us to identify pathways critical to leukemias and lymphomas.
CRI's generous and continued support of our research in cancer immunology and cancer immunotherapy helped us to establish a sustainable clinical research and teaching/training program in the field. New students and young researchers were introduced to the field as MD/PhD students and young faculty. CRI's CVC helped to establish a Clinical Trials Center at the University of Zurich. Ultra-lean management and great communication skills with an outstanding scientific faculty advising characterize CRI's success as a non-profit organization focused on Cancer Immunology and Cancer Immunotherapy.
I was awarded a CRI postdoc fellowship a few years ago, which turns me from a scientific worker to a scientist. The critical difference between these two is that the later endowed with a great passion and motivation for research which grew in me during this postdoctoral training phases. Without the support from CRI, this transformation will not likely happen. Thank CRI for training young people in the cancer research field, and I believe our research will eventually provide great benefits for cancer patients.
During my postdoctoral studies at the section of Immunobiology at Yale Medical School I have been a CRI fellow studying the transcriptional regulation of cytokine genes driving the differentiation processes of T helper cells. During that period, and having peace of mind because CRI was funding my research, we were able to advance our knowledge about gene regulation and show that the three dimensional structure of the genome affects the expression profile of a locus. More importantly others have shown that proximity of gene loci in the 3D nucleus increase the probability for a translocation event usually found in leukemia and tumors.
The funding I have received during my postdoctoral studies was of fundamental importance and helped me get an Assistant Professorship. And again my good angel CRI was there to support my research with an Investigator award. This gave a kickstart to my career and my first steps as an independent investigator. I am really proud being part of this team of people who are dedicated and hard working with the ultimate goal of conquering cancer.
I was the recipient of a CRI postdoctoral fellowship award that funded my research in the function of the innate immune system during aging at MIT. Because of the generous support of CRI, I was able to make important discoveries that I anticipate will help to form the foundation of further study in age-dependent dynamics of signaling pathways that regulate the immune response later in life. Throughout my years as a CRI fellow, I have found the staff at CRI to be professional, supportive, and truly dedicated to the cause of advancing scientific knowledge toward the goal of eliminating cancer. My heartfelt thanks goes to CRI, and I would strongly recommend CRI as a benefactor of those seeking to support biomedical research.
The Cancer Research Institute by wisely selecting and generously supporting investigators and projects on cancer research has immensely contributed to advance our understanding of malignancies, thus paving the way for novel therapies. With the support of the CRI we have developed new MHC-peptide based reagents that allow improved detection and isolation of antigen-specific CD8+ and CD8+ T lymphocytes. We endeavour after final optimization to make these reagents generally available, thus contributing to better monitor and understand cancer specific T cell immunity.
Twenty five years ago I received a posdoctoral fellowship from the CRI. This allowed me to get an unvaluable training in the field of cancer immunology that was the start of my scientific career. CRI did not mind the fact that I was a young physician just arrived in the US, and generously funded my research. CRI is the perfect example of a phylantropic organization in the frontier of new knowledge and humankind. I am now a top administrator of one of the largests European Universities and I remain grateful to CRI for their support.
As a former recipient of Cancer Research Institute postdoc fellowship, I am very grateful to CRI for the generous support to allow me to carry out frontier research work in chemical biology at Harvard University. It was an eye opening experience that not only broadened my understanding at the interface of chemistry and biology, but also gave me an inspiration to choose my own research topic related to cancer and immunology. In my independent academic work, I have benefited tremendously from that postdoctoral experience and I am glad I have made the right decision to develop new anticancer drugs.
In 2008, the Cancer Research Institute was the only agency that was
willing to fund a risky project whose objective it is to understand
why the immune system fails in the elderly. Since then, this study has
yielded exciting results on how aging of stem cells influences immune
function and we are currently preparing two manuscripts on our work.
We have recently procured a grant by the National Institute on Aging,
totaling $658,000, to follow up on these results. Obviously, we would
not have been able to undertake this project without the visionary
support of the Cancer Research Institute.
I was a recipient of funding from the CRI to conduct my postdoctoral research and I am a yearly donor to this institute. I am very positive about the CRI and their mission because they get results. They understand the process of discovery and innovation well enough to invest in basic research of the immune system because the findings that come from such basic studies are the building blocks of translational research. And, they have the vision to support efforts to take key basic findings from the bench to the bedside. A key case in point is the development of the immunotherapeutic drug Ipilimumab, which the CRI helped advance, as a treatment for melanoma.
I and my extended group have been the recipients of a ”matching grant”, awarded jointly by the Cancer Research Institute and the Concern Foundation, Los Angeles, over several years. This grant was used to support the work of 10-15 fellows each year, working in the areas of cancer cell genetics, tumor virology and tumor immunology. This generous grant has given us an unparalleled opportunity to pursue the research with a dynamic group of research fellows, postdoctorals and guest investigators. With the help of this grant we could keep talented young researchers who would have been otherwise forced into industry or other applied work.
The Cancer Research Institute has my greater admiration for the highly efficient, non-bureaucratic, talent- and problem-oriented support that characterizes their fellowship program.
I was supported by CRI for my Postdoctoral fellowship, and it provided me a wonderful period to study and work in one of the best lab of cancer immunology in the world. The society of CRI also have been providing me a opportunity to communicate with great scientists. Annual meeting in NY always stimulates me a lot when I attend.
For the past 3 years, the Cancer Research Institute has supported a postdoctoral fellow in my laboratory. With federal funding for biomedical research in decline, much important research related to cancer (and literally any other human disease) could not be done without the dedicated and unwavering support from private non-profit organizations like the Cancer Research Institute. The high standards during the initial peer review of projects, the continued support and the annual meeting all provide outstanding opportunities for young investigators to learn and to network with other professionals in their fields.
the Cancer Research Institute not only funded my postdoctoral research in tumor immunology but inserted me into the perfect environment to start building my research career. Through their PhD, postdoctoral and new investigator awards programs plus their anual meetings, the CRI puts together an impressive group of scientists all with different expertises and ideas but at the same time all with the same general goal: to defeat cancer.
The caliber of the scientists involved in CRI is simply outstanding, and the fact that many times a year they are all put together in the same room to discuss failures and successes in our fight against cancer has definitively yielded promising results. This is the perfect environment to be inserted as a young investigator and I am really grateful to have had the opportunity to be part of this group of scientist. Most importantly, the network of scientists generated under CRI's umbrella is a permanent one, as investigators continue to interact and collaborate in cancer related projects for much longer than their CRI sponsored funding.
CRI is much more than a charity or funding agency, is truly an incubator for fantastic science, research and development.
The funding provided by CRI allowed me to support a wonderfully talented postdoctoral fellow from Africa to embark on an almost entirely unexplored area of research relevant to human infectious diseases, autoimmune disease and cancer. These studies open up an important new area of research specifically related to human immunology. Because of hard work and enthusiasm this fellow has made much additional progress on investigations related to the understanding of a spectrum of virus-associated cancers that occur word-wide, to autoimmune disease and tumor immunology; moreover this young scientist is now well on the way to an independent career. Without the constant support of CRI this would not have been possible.
I am an Immunology researcher and have received funding from the Cancer Research Institute for my laboratory. As a new investigator, the CRI funding allowed me to get my research started quickly and allowed me to get results allowing me to successfully compete for NIH funding for my research focused on immunology, inflammation and autoimmune disease.
I was a recipient of 3 year postdoctoral fellowship from CRI. I think CRI is playing a crucial role in supporting young scientists to develop their career. It role is very important for our future of science, particularly when public funding is affected by economic crisis and politics.
I received three years fellowship from CRI for my research at the university of Chicago. This fellowship helped us to start a very competitive project . CRI grants help many labs to fund important research works especially when other funding sources are affected due to economic crisis. CRI is doing a great job of providing stable fundings . This allows us to focus on our research. I appreciate CRI's commitment towards science. I am very proud of being a part of CRI community.